Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PHGUF
Stock Latest News
Company Announcements
Pharming Group Balances Near-Term Strain With Joenja Growth
2d ago
Premium
The Fly
Pharming price target lowered to $40 from $41 at Oppenheimer
14d ago
PHAR
Premium
Company Announcements
Pharming Group Balances Short-Term Strain With Pipeline Gains
14d ago
Premium
The Fly
Pharming reports Q1 EPS 1c, consensus 0c
15d ago
PHAR
Premium
The Fly
Pharming sees FY26 revenue $405M-$425M, consensus $411.9M
15d ago
PHAR
Premium
The Fly
Pharming initiated with a Buy at Canaccord on growth potential
1M ago
PHAR
Premium
The Fly
Pharming initiated with a Buy at Canaccord
1M ago
PHAR
Premium
The Fly
Pharming announces approval of Joenja in Japan for patients aged 4 years and old
2M ago
PHAR
Premium
The Fly
Pharming price target lowered to $41 from $42 at Oppenheimer
2M ago
PHAR
Premium
Ratings
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
2M ago
PHAR
Premium
Pre-Earnings
Is PHGUF a Buy, Before Earnings?
2M ago
Premium
The Fly
Morning Movers: Disney dips following fourth quarter earnings
4M ago
DIS
DVN
Premium
The Fly
Pharming to host virtual investor day
4M ago
PHAR
Premium
Company Announcements
Pharming Hit by FDA Setback on Joenja Pediatric Expansion but Adult Approval Unaffected
4M ago
Premium
The Fly
Pharming receives CRL from U.S. FDA for sNDA for Joenja
4M ago
PHAR
Premium
The Fly
Pharming price target raised to $42 from $41 at Oppenheimer
7M ago
PHAR
Premium
Company Announcements
Pharming Group Reports Strong Q3 2025 Growth
7M ago
Premium
Company Announcements
Pharming Group N.V. Reports Strong Q3 2025 Earnings
7M ago
Premium
Pre-Earnings
PHGUF Upcoming Earnings Report: What to Expect?
7M ago
Premium
The Fly
Pharming announces 20% net reduction in non-commercial, non-medical headcount
8M ago
PHAR
Premium
Ratings
Pharming Group’s Leniolisib Gains FDA Approval for Pediatric Use, Expanding Market Potential
8M ago
PHAR
Premium
The Fly
= Pharming Group NV ADS trading resumes
10M ago
PHAR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
